drugset / Trial / NCT03535233

Topical 5% Minoxidil and Potent Topical Corticosteroid Versus Intralesional Corticosteroid in the Treatment of Alopecia Areata

NCT03535233

Phase 4 Completed 40 enrolled Cairo University
RandomizedParallel-groupSingle-blindTreatment

Summary

Alopecia areata (AA) presents with circumscribed patches of non-scarring hair loss. It inflects a significant psychological and social burden. Many treatment options are used for the treatment of AA. Randomized controlled trials comparing intralesional and topical therapy and comparing combinations are few. The aim of this work is to evaluate the efficacy of combined topical 5% minoxidil and potent topical corticosteroid therapy compared to intralesional triamcinolone injection in alopecia areata

Timeline

Start
2016-03
Primary completion
2017-06
Completion
2017-09

Drugs

EvaluationDrugModalityDoseRoute
Comparator Minoxidil Small molecule 5 % Topical
Comparator Triamcinolone Acetonide Other / unclassified 5 mg/ml Intramuscular
Comparator clobetasol propionate Small molecule 0.05 % Topical

Indications